FDA Warns of Ketoacidosis with Certain Diabetes Drugs
An article on the American Academy of Family Physicians’ website discussed the FDA’s recent move to add warnings to the labels of diabetes drugs like Invokana to notify users about the potential risk of ketoacidosis. The article also cautioned physicians whose patients are on these diabetes drugs to watch for signs of ketoacidosis and to make patients aware of the symptoms so they can seek medical attention should symptoms appear. The FDA also noted that while a number of adverse events have been reported with Invokana and other SGLT2 Inhibitor diabetes drugs, the actual number of adverse events is most likely higher since the reporting is done on a voluntary basis only.
Learn More About Invokana lawsuits
The Feeney Law Firm provides additional information about dangerous drugs on our Invokana lawsuit page. Our firm is dedicated to those who have been affected by Invokana. If you or a loved one has suffered serious injuries due to Invokana, then call us immediately at 1-800-809-0911 for your FREE consult. You may be entitled to compensation, so do not delay. Your time to file a claim may be limited.